BeOne Medicines (BEIGF) EBIT Margin Growth (3y) (2018 - 2026)
BeOne Medicines (BEIGF) EBIT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
- |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
9,942.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
9,942.00 |
| Dec 31, 2025 |
13,564.00 |
| Sep 30, 2025 |
12,464.00 |
| Jun 30, 2025 |
13,532.00 |
| Mar 31, 2025 |
14,556.00 |
| Dec 31, 2024 |
-9,610.00 |
| Sep 30, 2024 |
21,194.00 |
| Jun 30, 2024 |
30,504.00 |
| Mar 31, 2024 |
-4,635.00 |
| Dec 31, 2023 |
42,393.00 |
| Sep 30, 2023 |
46,610.00 |
| Jun 30, 2023 |
49,323.00 |
| Mar 31, 2023 |
63,504.00 |
| Dec 31, 2022 |
55,877.00 |
| Sep 30, 2022 |
50,969.00 |
| Jun 30, 2022 |
-7,142.00 |
| Mar 31, 2022 |
7,867.00 |
| Dec 31, 2021 |
56,768.00 |
| Sep 30, 2021 |
5,482.00 |
| Jun 30, 2021 |
-779.00 |
